Acute kidney injury (AKI) is very common in major surgeries and about 36% of ICU patients, it increases mortality, treatment costs and prolonged ICU stay, although currently trying to develop treatments to prevent or mitigate AKI, but with little success. And nowadays, the kidney biomarker is applied in this field, which has made some great achievement.
